Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients

University of Brasília. Tropical Medicine Centre. Brasília, DF, Brazil / Fundação Oswaldo Cruz. Brasília, DF, Brasil
Federal University of Goiás. Tropical Pathology and Public Health Institute. Goiânia, GO, Brazil
Federal University of Ceará. Department of Public Health. Fortaleza, CE, Brazil
Federal University of Goiás. Tropical Pathology and Public Health Institute. Goiânia, GO, Brazil
London School of Hygiene and Tropical Medicine. Department of Infectious and Tropical Diseases.London England
Federal University of Minas Gerais. Clinical Hospital. Dermatology Department. Belo Horizonte, MG, Brazi
Federal University of Minas Gerais. Clinical Hospital. Dermatology Department. Belo Horizonte, MG, Brazi
Federal University of Minas Gerais. Clinical Hospital. Dermatology Department. Belo Horizonte, MG, Brazi
Federal University of Goiás. Medicine Faculty. Goiania, GO, Brazil
Lauro de Souza Lima Institute, Bauru, SP, Brazil
Dona Libania Dermatology Centre. Fortaleza, CE, Brazil
Tropical Dermatology and Venerology Alfredo da Matta Foundation. Manaus, AM, Brazil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil
Dona Libania Dermatology Centre. Fortaleza, CE, Brazil
Federal University Fluminense. Epidemiology and Biostatistics Department. Niteroi, RJ, Brazil

Resumen en ingles

Leprosy control is based on early diagnosis and multidrug therapy. For treatment purposes, leprosy patients can be classified as paucibacillary (PB) or multibacillary (MB), according to the number of skin lesions. Studies regarding a uniform treatment regimen (U-MDT) for all leprosy patients have been encouraged by the WHO, rendering disease classification unnecessary.

Palabras clave en portugues

Hanseníase Multibacilar
Fatores de Tempo
Diagnóstico precoce
Tuberculose resistente a drogas
Resultado do tratamento
Humanos
Brasil

Palabras clave en ingles

Leprosy, Multibacillary
Time Factors
Early diagnosis
Drug Resistant Tuberculosis
Treatment Outcome
Humans
Brazil

Editor

Public Library of Science

Referencia

PENNA, G. O. et al. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients. PLoS Neglected Tropical Diseases, v. 11, n. 7, p. e0005725, 2017.

DOI

10.1371/journal.pntd.0005725

ISSN

1935-2727

Por favor, use este identificador para citar o enlazar este ítem: https://www.arca.fiocruz.br/handle/icict/25529

Tipo

Derechos de autor

Acceso abierto

Colecciones

Compartir

Estadísticas

Metadatos

Autor

Afiliación